ArticleThe Iowa orthopaedic journal2026
Pediatric Achilles Tendon Ruptures in the United States: an Evaluation of National Practice Patterns, Management Trends, Complications and 2-Year Failure Rates.
Article in The Iowa orthopaedic journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Achilles tendon ruptures, though uncommon in the pediatric population, present significant clinical challenges due to the unique biomechanical and physiological characteristics of developing tissues. While adult management is well studied, the optimal pediatric approach remains unclear, with limited large-scale studies on this topic. This study aims to evaluate national trends in the incidence and management of pediatric Achilles tendon ruptures in the United States and compare short-term complication rates and longterm outcomes between operative and nonoperative approaches. Methods: A retrospective cohort study using the PearlDiver database identified pediatric patients (ages 0-18) diagnosed with Achilles tendon ruptures from 2016 to 2022. Patients were stratified by rupture type (open vs. closed) and management (operative vs. nonoperative). Population-normalized incidence rates were assessed by age group. A subset with a minimum 2 years of follow-up was analyzed for complications, including 90-day infection, nerve injury, and wound complication rates, as well as two-year ankle fracture and failure rates. Statistical analyses included Student's t-tests, chisquare tests, and linear regression. Results: A total of 18,441 pediatric patients with Achilles tendon ruptures were identified. Most injuries (88.0%) were in the 10-18 year age group with an even distribution of males and females (50% each). Most ruptures were closed (99.2%) and managed nonoperatively (97.4%), with nonoperative treatment more common in closed vs. open ruptures (97.6% vs. 71.5%, p<0.001). From 2016 to 2022, rupture incidence declined across all age groups (p<0.05), most notably in ages 1014 (p=0.004). The distribution of operative vs. nonoperative management remained unchanged. Complication rates were higher in the operative cohort compared to the nonoperative cohort: infections (5.07% vs. 0.32%), nerve injuries (0.68% vs. 0.03%), wound complications (1.01% vs. 0.04%), two-year failure (5.74% vs. 0.10%), and ankle fracture (1.69% vs. 0.75%), though statistical comparison was limited by low event counts. Conclusion: The incidence of pediatric Achilles tendon ruptures has declined significantly over the past decade. Nonoperative management remains the dominant treatment approach and is associated with low complication and failure rates. These findings highlight the importance of careful patient selection for operative intervention. Level of Evidence: III.
Indexed as
Identifiers
42488315PMC13389462What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.